Open-Angle Glaucoma: What Patients Need to Know
What Is Open-Angle Glaucoma?
Open-angle glaucoma is a chronic eye disease caused by a gradual rise in pressure inside the eye that, over time, damages the optic nerve. Understanding what makes this condition unique helps explain why early detection is so critical.
The eye constantly produces a clear fluid called aqueous humor, which normally drains out through a spongy tissue called the trabecular meshwork. In open-angle glaucoma, this drainage system becomes less efficient over time, even though the drainage angle between the iris and cornea remains physically open. As fluid accumulates and pressure rises, the optic nerve begins to sustain damage that cannot be reversed.
The term 'open-angle' distinguishes this form from angle-closure glaucoma, where the drainage pathway becomes suddenly and physically blocked, often requiring emergency treatment. In open-angle glaucoma, the angle stays open but the microscopic drainage channels within the trabecular meshwork gradually lose efficiency. The pressure rise is slow and silent, which is what makes this condition so easy to miss without regular eye exams.
Primary open-angle glaucoma has no identifiable underlying cause and is by far the most common type. Secondary open-angle glaucoma develops as a result of another condition, such as pseudoexfoliation syndrome (where protein deposits clog the drainage system) or pigment dispersion syndrome (where pigment particles shed from the iris obstruct outflow). Normal-tension glaucoma is a distinct form in which the optic nerve is damaged even when eye pressure measures within the normal range, often related to reduced blood flow to the nerve.
The earliest vision loss typically occurs in the peripheral (side) field of vision, often going unnoticed because the brain partially compensates for the missing information and central vision remains intact. Without treatment, the field of vision continues to narrow, eventually creating tunnel vision. By the time many patients notice a change, a meaningful amount of irreversible optic nerve damage may have already occurred.
Who Is at Risk?
Certain factors significantly increase a person's likelihood of developing open-angle glaucoma. Knowing your personal risk profile can help you and your eye doctor decide how often to schedule screenings and when to consider preventive treatment.
The risk of open-angle glaucoma increases with age, particularly after 60, though for individuals of African descent that risk rises meaningfully starting around age 40. Having a parent or sibling with glaucoma increases personal risk substantially, because the condition has a strong genetic component. Anyone with a first-degree relative diagnosed with glaucoma should discuss earlier and more frequent screening with their eye doctor.
People of African and Hispanic descent face a higher risk of developing primary open-angle glaucoma at a younger age and with a more aggressive course. Individuals of Asian descent are more commonly affected by normal-tension glaucoma. These differences are important factors in determining when to start screening and how closely to monitor progression.
Several characteristics of the eye itself raise the risk of developing glaucoma or experiencing faster progression. These include elevated intraocular pressure (ocular hypertension), thin corneas, high nearsightedness (myopia), a history of eye injury or inflammation, and a large or asymmetric optic nerve cup. Each of these factors is evaluated during a comprehensive glaucoma workup.
Conditions such as diabetes, high blood pressure, sleep apnea, and cardiovascular disease can affect blood flow to the optic nerve and contribute to glaucoma risk or progression. Long-term use of corticosteroid medications, whether as eye drops, oral pills, or inhalers, is also associated with elevated eye pressure and should always be disclosed to your eye doctor.
Recognizing Symptoms
Open-angle glaucoma is widely known as the 'silent thief of sight' because meaningful symptoms rarely appear until the disease has reached an advanced stage. This characteristic makes a proactive screening schedule essential for anyone at elevated risk.
In the earliest phases of open-angle glaucoma, most patients experience no pain, no visual disturbance, and no warning of any kind. The eye pressure rise is gradual, and the optic nerve loss begins in areas of side vision that the brain quietly compensates for. This absence of symptoms is precisely why glaucoma can cause substantial, irreversible damage before it is ever noticed.
As the disease advances, patients may begin to notice difficulty in low-light environments, trouble with stairs or curbs, or a tendency to bump into objects in their peripheral field. These changes develop slowly over months or years and are often attributed to normal aging rather than recognized as signs of glaucoma. If you or a family member notice any of these patterns, an eye exam is warranted.
In severe, untreated cases, the visual field narrows to a small central tunnel, making activities like driving, reading in a crowd, or navigating unfamiliar spaces increasingly difficult. Once central vision becomes involved, the level of optic nerve damage is already significant and further loss becomes harder to prevent. This is why treatment well before reaching this stage is the primary goal.
Sudden eye pain, nausea, an abrupt decrease in vision, or rainbow-colored halos around lights are warning signs of acute angle-closure glaucoma, a distinct and urgent condition that requires immediate evaluation. If you experience any of these symptoms, do not wait for a scheduled appointment. Seek emergency eye care right away.
Diagnosis and Testing at Rhode Island Eye Institute
Diagnosing open-angle glaucoma accurately requires a combination of complementary tests that together reveal the full picture of eye pressure, drainage anatomy, optic nerve health, and visual function. Our glaucoma specialists use a comprehensive, state-of-the-art diagnostic approach tailored to each patient.
Tonometry measures the pressure inside the eye, a key indicator of glaucoma risk. The test is quick and painless, typically performed with a small probe after numbing drops are applied or with a non-contact puff of air. Because glaucoma can occur even when pressure is within the standard normal range, tonometry is always interpreted alongside the full clinical picture rather than in isolation.
Gonioscopy uses a specialized contact lens placed gently on the numbed eye to give the eye doctor a direct view of the drainage angle. This test is essential for confirming that the angle is truly open and for identifying secondary causes of glaucoma, such as pigment deposits or pseudoexfoliative material that may be clogging the drainage system. It also helps distinguish open-angle from angle-closure forms, which require different management strategies.
Automated visual field testing maps the complete extent of your field of vision to identify any areas of loss caused by optic nerve damage. During the test, you look straight ahead at a screen and press a button each time you detect a small flash of light appearing at various locations around your field of view. This test is performed at baseline and repeated regularly to detect any change in the pattern or extent of vision loss over time.
Optical coherence tomography, or OCT, produces detailed cross-sectional images of the optic nerve and the surrounding retinal nerve fiber layer, the part of the retina most directly affected by glaucoma. This technology can detect subtle structural changes earlier than they would appear on a standard examination. Color stereoscopic optic nerve photography complements OCT by providing a visual record of the nerve's appearance that can be compared across visits to track any progression.
Treatment Options
The goal of glaucoma treatment is to lower intraocular pressure enough to prevent further damage to the optic nerve and preserve the vision you have. Treatment is not a one-size-fits-all decision, and our team works closely with each patient to find the right approach for their individual situation.
For most patients, prescription eye drops are the first line of treatment. These medications work by either reducing the amount of fluid the eye produces or by improving how efficiently fluid drains out of the eye. Several classes of drops are used in glaucoma care, including prostaglandin analogs, beta-blockers, alpha-adrenergic agonists, carbonic anhydrase inhibitors, and rho kinase inhibitors. Consistent daily use is essential because missing doses allows pressure to rise and puts the optic nerve at risk.
SLT is a safe, in-office laser procedure that improves the efficiency of the eye's natural drainage system by applying gentle pulses of laser energy to the trabecular meshwork. The procedure is quick and painless, requires no incisions, and can significantly lower eye pressure, sometimes reducing or eliminating the need for daily eye drops. SLT can be repeated if its effect diminishes over time, making it a flexible and valuable option in long-term glaucoma management.
MIGS refers to a group of newer surgical approaches that reduce intraocular pressure using small implants or devices with a significantly shorter recovery time and lower risk profile than traditional glaucoma surgery. These procedures often involve placing a microscopic stent or implant to enhance fluid outflow through the eye's natural drainage pathways. MIGS can be conveniently combined with cataract surgery, making it an efficient option for patients who need both procedures, and combined cataract-glaucoma surgery with premium intraocular lens implants is a specialty offering at our practice.
When eye drops, laser, and MIGS do not achieve adequate pressure control, traditional surgical options may be recommended. A trabeculectomy creates a new drainage channel that allows fluid to exit the eye through a small opening under the eyelid. Tube shunt surgery implants a small device that redirects fluid to a reservoir outside the eye. Both procedures are highly effective at achieving sustained, significant pressure reduction in advanced or difficult-to-control cases, and our surgical team has extensive experience with both.
For patients found to have a narrow or closeable drainage angle during gonioscopy, a laser iridotomy may be recommended as a preventive measure. This procedure creates a tiny opening in the iris to allow fluid to circulate more freely and prevent the angle from closing. While distinct from open-angle glaucoma treatment, identifying this risk during a comprehensive evaluation allows us to protect patients from a potentially sight-threatening episode before it occurs.
Living Well with Open-Angle Glaucoma
Managing glaucoma effectively is a long-term commitment that extends beyond clinic visits and medications. Everyday habits and lifestyle choices play a meaningful supporting role in protecting your optic nerve health alongside your prescribed treatment plan.
The single most important factor in glaucoma management is consistent adherence to prescribed eye drops. Setting phone reminders, linking drop use to a fixed daily routine, or using a tracking app can all help build a reliable habit. If you find it difficult to instill drops correctly, or if side effects are affecting your willingness to use them, talk with your eye doctor before stopping or altering your regimen on your own.
A diet rich in leafy green vegetables, colorful fruits, and foods containing omega-3 fatty acids supports general vascular and optic nerve health. Staying adequately hydrated is beneficial, though drinking very large quantities of fluid in a short period of time can temporarily raise eye pressure and should be avoided. Regular moderate aerobic exercise such as walking, swimming, or cycling may help lower intraocular pressure and improve optic nerve blood flow. Discuss high-intensity activities like heavy weightlifting or inverted yoga poses with your eye doctor, as these can temporarily elevate pressure and may need to be modified.
Glaucoma is a lifelong condition that requires ongoing monitoring even when it appears well controlled. Most patients with a confirmed diagnosis need follow-up evaluations every three to six months, with repeat visual field testing and OCT imaging at intervals determined by disease severity and stability. Never skip follow-up appointments, as subtle changes in pressure or nerve structure can occur even when vision feels unchanged.
Adjusting to a glaucoma diagnosis takes time, and many patients benefit from connecting with others in similar situations. Organizations like the Glaucoma Research Foundation offer reliable educational materials and community resources. For patients who have already experienced meaningful vision loss, low-vision specialists can provide tools, strategies, and assistive technology to help maintain independence and quality of life.
Frequently Asked Questions
These questions address common points of uncertainty and practical decision-making for patients navigating an open-angle glaucoma diagnosis or screening.
There is currently no cure for glaucoma, and damage that has already occurred to the optic nerve cannot be restored. However, the disease can be managed very effectively to slow or halt further progression. With the right treatment plan and consistent follow-through, the large majority of patients are able to preserve functional vision throughout their lifetime. The earlier the condition is identified and treated, the better the long-term outcome tends to be.
Dr. Sarah Anis is our fellowship-trained glaucoma and cataract surgeon, with advanced training completed at the Wilmer Eye Institute at Johns Hopkins and a research fellowship at the New York Eye and Ear Infirmary. She also serves as a Clinical Instructor in Surgery at Brown University. Dr. Anis specializes in the full spectrum of glaucoma care, from medical management and laser treatment to advanced surgical options, and is experienced in treating open-angle, angle-closure, and secondary glaucoma types including pseudoexfoliative and pigmentary glaucoma.
Yes. Normal-tension glaucoma is a recognized form of open-angle glaucoma in which optic nerve damage occurs despite intraocular pressure that measures within the standard normal range. This is one reason why a glaucoma evaluation includes much more than a pressure check. Optic nerve imaging, visual field testing, and gonioscopy together allow our team to identify damage that pressure readings alone would miss. If you have risk factors or a family history of glaucoma, a comprehensive exam rather than a pressure check alone is the appropriate screen.
For most patients, glaucoma management is an ongoing process that continues indefinitely. The treatment method may change over time as the disease evolves or as newer options become appropriate, but the underlying need to protect the optic nerve from further pressure-related damage does not go away. Some patients respond so well to laser treatment or surgery that their medication requirements decrease, but regular monitoring remains necessary regardless of how well pressure appears to be controlled.
Stopping glaucoma eye drops without medical guidance allows intraocular pressure to rise, often returning quickly to its pre-treatment level. Even a relatively short period of elevated pressure can contribute to additional, irreversible optic nerve damage. If you are experiencing side effects, cost concerns, or difficulty using your drops, please contact our office to discuss alternatives before discontinuing. There are usually other options available, and a solution can almost always be found.
For adults without specific risk factors, a baseline comprehensive eye exam is generally recommended around age 40. Those at higher risk, including individuals of African or Hispanic descent, anyone with a family history of glaucoma, people with elevated eye pressure, or those with thin corneas, should begin screening earlier and have exams more frequently. Your eye doctor can give you a personalized recommendation based on your individual risk profile during your first visit.
See a Glaucoma Specialist at Rhode Island Eye Institute
Protecting your vision from open-angle glaucoma starts with a comprehensive evaluation from specialists who have the training, technology, and experience to detect even the earliest signs of this condition. At Rhode Island Eye Institute, our glaucoma team brings fellowship-level expertise and state-of-the-art diagnostics together under one roof to provide the highest standard of care for patients across Rhode Island and beyond. If you have risk factors for glaucoma, a family history of the disease, or simply have not had a comprehensive eye exam recently, we encourage you to schedule an appointment with our team and take an active step toward protecting your long-term vision health.